CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
===============================================================================================================================

* Bryan D. Choi
* Xiaoling Yu
* Ana P. Castano
* Henia Darr
* Daniel B. Henderson
* Amanda A. Bouffard
* Rebecca C. Larson
* Irene Scarfò
* Stefanie R. Bailey
* Genevieve M. Gerhard
* Matthew J. Frigault
* Mark B. Leick
* Andrea Schmidts
* Jason G. Sagert
* William T. Curry
* Bob S. Carter
* Marcela V. Maus